Diagnostic value of [¹⁸F]FDG PET/MRI for staging in patients with ovarian cancer.

ABSTRACT:

Purpose

To evaluate the diagnostic potential of PET/MRI with 2-[¹⁸F]fluoro-2-deoxy-D-glucose ([¹⁸F]FDG) in ovarian cancer.

Materials and methods

Participants comprised 103 patients with suspected ovarian cancer underwent pretreatment [¹⁸F]FDG PET/MRI, contrast-enhanced CT (ceCT) and pelvic dynamic contrast-enhanced MRI (ceMRI). Diagnostic performance of [¹⁸F]FDG PET/MRI and ceMRI for assessing the characterization and the extent of the primary tumor (T stage) and [¹⁸F]FDG PET/MRI and ceCT for assessing nodal (N stage) and distant (M stage) metastases was evaluated by two experienced readers. Histopathological and follow-up imaging results were used as the gold standard. The McNemar test was employed for statistical analy

SUBMITTER: Tsuyoshi H 

PROVIDER: S-EPMC7532239 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature